FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2997775719> ?p ?o ?g. }

• W2997775719 endingPage "e85" @default.
• W2997775719 startingPage "e77" @default.
• W2997775719 abstract "Chimeric antigen receptor-engineered T (CART) cells are a promising new treatment option for patients with multiply relapsed and refractory (R/R) diffuse large B cell lymphoma (DLBCL). Because of the favorable outcome data reported for CART cells, uncertainty is emerging if there is still a role for allogeneic hematopoietic cell transplantation (allo-HCT) in the treatment of R/R DLBCL. This article provides an overview of available evidence and theoretical considerations to put these 2 types of cellular immunotherapy (CI) into perspective. Altogether, current data suggest that CART cells are preferred now over transplantation as first-choice CI in many clinical situations. However, the majority of patients will fail CART therapy, resulting in an unmet medical need where allo-HCT could be beneficial. In contrast, employing allo-HCT instead of CART cells as first CI should be presently restricted to situations where CART cell therapy is deemed not feasible or useful, such as patients with refractory cytopenia or incipient myelodysplastic syndrome. However, allo-HCT remains a standard treatment option as first CI for patients with chemosensitive R/R DLBCL when CARTs are not available or transplantation is preferred by the patient. Continuous collection and analysis of CI outcome data by professional registries appear to be of key importance for developing rational strategies of CI allocation and sequencing." @default.
• W2997775719 created "2020-01-10" @default.
• W2997775719 creator A5008706897 @default.
• W2997775719 creator A5011030256 @default.
• W2997775719 creator A5069393942 @default.
• W2997775719 creator A5077430940 @default.
• W2997775719 creator A5085146093 @default.
• W2997775719 creator A5086815330 @default.
• W2997775719 date "2020-04-01" @default.
• W2997775719 modified "2023-10-16" @default.
• W2997775719 title "Cellular Immunotherapy for Refractory Diffuse Large B Cell Lymphoma in the Chimeric Antigen Receptor-Engineered T Cell Era: Still a Role for Allogeneic Transplantation?" @default.
• W2997775719 cites W1755350398 @default.
• W2997775719 cites W1994410077 @default.
• W2997775719 cites W2003327619 @default.
• W2997775719 cites W2011695815 @default.
• W2997775719 cites W2021130630 @default.
• W2997775719 cites W2023068069 @default.
• W2997775719 cites W2037010003 @default.
• W2997775719 cites W2038062093 @default.
• W2997775719 cites W2040663943 @default.
• W2997775719 cites W2062437906 @default.
• W2997775719 cites W2066175494 @default.
• W2997775719 cites W2072267427 @default.
• W2997775719 cites W2075606933 @default.
• W2997775719 cites W2087137028 @default.
• W2997775719 cites W2097426308 @default.
• W2997775719 cites W2100007574 @default.
• W2997775719 cites W2136060045 @default.
• W2997775719 cites W2143775811 @default.
• W2997775719 cites W2152197116 @default.
• W2997775719 cites W2155313625 @default.
• W2997775719 cites W2165885469 @default.
• W2997775719 cites W2179179262 @default.
• W2997775719 cites W2300560420 @default.
• W2997775719 cites W2305142474 @default.
• W2997775719 cites W2515536126 @default.
• W2997775719 cites W2520356485 @default.
• W2997775719 cites W2604605580 @default.
• W2997775719 cites W2751416367 @default.
• W2997775719 cites W2754562068 @default.
• W2997775719 cites W2761108028 @default.
• W2997775719 cites W2763751953 @default.
• W2997775719 cites W2766745670 @default.
• W2997775719 cites W2768810256 @default.
• W2997775719 cites W2773804840 @default.
• W2997775719 cites W2775369717 @default.
• W2997775719 cites W2785888599 @default.
• W2997775719 cites W2787301955 @default.
• W2997775719 cites W2792232222 @default.
• W2997775719 cites W2799756006 @default.
• W2997775719 cites W2801641802 @default.
• W2997775719 cites W2809013389 @default.
• W2997775719 cites W2889921858 @default.
• W2997775719 cites W2900884053 @default.
• W2997775719 cites W2901133714 @default.
• W2997775719 cites W2903062212 @default.
• W2997775719 cites W2903225254 @default.
• W2997775719 cites W2904192212 @default.
• W2997775719 cites W2904820558 @default.
• W2997775719 cites W2905654445 @default.
• W2997775719 cites W2910655165 @default.
• W2997775719 cites W2911045905 @default.
• W2997775719 cites W2912570117 @default.
• W2997775719 cites W2914763076 @default.
• W2997775719 cites W2916176185 @default.
• W2997775719 cites W2916606137 @default.
• W2997775719 cites W2935210822 @default.
• W2997775719 cites W2944689312 @default.
• W2997775719 cites W2945828741 @default.
• W2997775719 cites W2945894787 @default.
• W2997775719 cites W2952250181 @default.
• W2997775719 cites W2953462331 @default.
• W2997775719 cites W2953936851 @default.
• W2997775719 cites W2956358944 @default.
• W2997775719 cites W2959588651 @default.
• W2997775719 cites W2963496214 @default.
• W2997775719 cites W2969216121 @default.
• W2997775719 cites W2974108516 @default.
• W2997775719 cites W2983410311 @default.
• W2997775719 cites W2984613450 @default.
• W2997775719 cites W2984927918 @default.
• W2997775719 cites W2985934220 @default.
• W2997775719 cites W2986196170 @default.
• W2997775719 cites W2986264979 @default.
• W2997775719 cites W2986497912 @default.
• W2997775719 cites W2987075075 @default.
• W2997775719 cites W2987192889 @default.
• W2997775719 cites W2987579816 @default.
• W2997775719 cites W2989906345 @default.
• W2997775719 cites W2990485716 @default.
• W2997775719 cites W2990627596 @default.
• W2997775719 cites W2991231480 @default.
• W2997775719 cites W2991246146 @default.
• W2997775719 doi "https://doi.org/10.1016/j.bbmt.2019.12.771" @default.
• W2997775719 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7207150" @default.
• W2997775719 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31917272" @default.
• W2997775719 hasPublicationYear "2020" @default.
• W2997775719 type Work @default.

• next